Drug interactions
Oxybutynin transdermal + Trihexyphenidyl
Severity: Moderate
Oxybutynin transdermal and Trihexyphenidyl: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Transdermal oxybutynin delivers systemic antimuscarinic exposure, although with less active metabolite than oral forms. Combined with trihexyphenidyl it may increase dry mouth, constipation, urinary retention, blurred vision and cognitive effects.
What this interaction means in plain words
Oxybutynin transdermal and Trihexyphenidyl can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive muscarinic receptor antagonism.
What to do
Monitor for anticholinergic adverse effects and cognitive changes, especially in older adults, and reduce doses if they occur.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Oxybutynin transdermal and Trihexyphenidyl, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Trihexyphenidyl
Frequently asked questions
Can I take Oxybutynin transdermal with Trihexyphenidyl?
MediHelp rates the interaction as moderate. Oxybutynin transdermal and Trihexyphenidyl can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Transdermal oxybutynin delivers systemic antimuscarinic exposure, although with less active metabolite than oral forms. Combined with trihexyphenidyl it may increase dry mouth, constipation, urinary retention, blurred vision and cognitive effects.
How serious is the interaction between Oxybutynin transdermal and Trihexyphenidyl?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for anticholinergic adverse effects and cognitive changes, especially in older adults, and reduce doses if they occur.
What other medicines interact with Trihexyphenidyl?
MediHelp also lists interactions of Trihexyphenidyl with, for example, Orphenadrin, Oxybutynin, Scopolamine. The full list is on the Trihexyphenidyl page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
